NEW YORK (GenomeWeb News) – Invitrogen said today that it has acquired VisiGen Biotechnologies, a developer of real-time single-molecule sequencing technology, for $20 million.
Invitrogen disclosed the purchase as part of its third-quarter financial report, in which it recorded a 15 percent increase in revenues to $362 million from $315 million in the third quarter of 2007.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.